Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

• Status: Unknown status
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Walter Reed Army Medical Center
• Treatments: Apraclonidine; Brimonidine Tartrate

Criteria

Inclusion Criteria:

• male or female, at least 18 years of age

• Open Angle Glaucoma with inadequate intraocular pressure (IOP) control or evidence of progression (based on optic nerve head appearance and/or visual field changes) despite current medical therapy

• Ocular Hypertension requiring lowering of IOP

• ability to understand and provide informed consent to participate in this study and willingness to follow study instructions and likely to complete all required visits

Exclusion Criteria:

• inability to understand and provide informed consent to participate in this study

• inability/unwillingness to follow study instructions and complete all required visits

• Documented allergy to either brimonidine or iopidine

• Angle Closure Glaucoma

• Congenital/Juvenile Glaucoma

• Neovascular Glaucoma

• Active uveitis